TOPIC:Â Vigabatrin for Oral Solution USP, 500 mg by InvaGen Pharmaceuticals:Â Recall – Due to Leaking Sachets AUDIENCE:Â Patient, Health Professional, Pharmacy, Pediatric, Neurology ISSUE:Â InvaGen Pharmaceuticals is recalling one lot, NB301030, of Vigabatrin for...
The Dup15q Alliance is aware of the recent release by the FDA regarding Keppra, Keppra XR, Elepsia XR, Spritam (levetiracetam) and Onfi, Sympazan (clobazam) warning about the risk of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). This adverse event is...
The Angelman Syndrome Foundation and the Dup15q Alliance are proud to announce plans to launch a new clinic at Children’s Hospital of Philadelphia (CHOP) to better serve the Angelman and Dup15q communities. AURORA, Ill., Oct. 11, 2023 /PRNewswire-PRWeb/ —...
Congratulations to Nadia Wallace, an undergraduate working in Dr. Lawrence T. Reiter’s lab, on being the second recipient of the Lucas T. Ahn Family Scholarship! “At the Neurology department of UTHSC in Dr. Reiter’s lab, I dedicate my time to finding...
Our friends at the Epielpsy Foundation have shared the Following Medication Recall The company that makes Sabril® (vigabatrin) for oral solution, a prescription medication to manage seizures in children and adults, has announced a recall of this medication because of...
